Who are in the management team of Blueprint Medicines Corp.?

Jun 22 2025 10:35 PM IST
share
Share Via
As of March 2022, the management team of Blueprint Medicines Corp. includes CEO Jeffrey Albers and Independent Chairman Daniel Lynch, along with several independent directors: Alexis Borisy, Lonnel Coats, George Demetri, Mark Goldberg, and Nicholas Lydon. The team consists of both executive leadership and independent directors.
As of March 2022, the management team of Blueprint Medicines Corp. includes the following individuals:

- Mr. Daniel Lynch, who serves as the Independent Chairman of the Board.
- Mr. Jeffrey Albers, who is the Chief Executive Officer and a Director.
- Mr. Alexis Borisy, who is a Director.
- Mr. Lonnel Coats, who is an Independent Director.
- Dr. George Demetri, who is an Independent Director.
- Dr. Mark Goldberg, who is an Independent Director.
- Dr. Nicholas Lydon, who is an Independent Director.

In summary, the management team is comprised of a mix of executive leadership and independent directors.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Is Blueprint Medicines Corp. overvalued or undervalued?
Sep 20 2025 06:26 PM IST
share
Share Via
Is Blueprint Medicines Corp. overvalued or undervalued?
Jun 25 2025 09:04 AM IST
share
Share Via
What does Blueprint Medicines Corp. do?
Jun 22 2025 06:48 PM IST
share
Share Via
How big is Blueprint Medicines Corp.?
Jun 22 2025 06:04 PM IST
share
Share Via